Abstract:In acute inflammation, macrophages polarises its phenotype in order to participate effectively in the inflammatory, anti-inflammatory and resolving phases. Particularly, the resolving phase is vital for homeostatic recovery. The murine peritonitis model had identified various subtypes of resolving macrophages. However, the model has limitations in deciphering the molecular mechanisms required for resolving macrophage polarisation. Therefore the aim of this study is to establish an model that could simplify the reproduction of resolving macrophage polarisation. This model will be a useful tool to screen for molecular mechanisms essential for triggering resolution. Our model showed Raw 264.7 cells exhibited classical inflammatory-like (M1-like) phenotype between 2-24 h with increased interleukin-1β expression and tumour necrosis factor-α secretion. Concurrently, at 22-24 h there was an increase in Raw 264.7 cells polarising to anti-inflammatory like (M2-like) phenotype. These M2-like macrophages were increased in arginase activity and interleukin-10 expression. By 48 h, Raw 264.7 cells were polarised to resolving-like (Mres-like/CD11b ) phenotype. These macrophages were characterised by high efferocytic index and a decrease in inflammatory cytokine expression, low arginase activity and low CD11b expression. In summary, this resolution model showed resolving-like polarisation in a macrophage cell line.

What problem does this paper attempt to address?

This paper attempts to address the problem of how to establish an in vitro model that can simulate the polarization of resolving macrophages during the acute inflammation process. Specifically, the researchers aim to develop an in vitro model to simplify and reproduce the polarization process of resolving macrophages, thereby better understanding the molecular mechanisms that trigger this process and providing tools for screening drugs that promote the resolution phase. ### Main Issues: 1. **Necessity of an In Vitro Model**: - **Limitations of In Vivo Models**: Existing in vivo mouse peritonitis models can identify different subtypes of resolving macrophages but are difficult to analyze the molecular and epigenetic mechanisms required for the polarization of these cells. This is due to the presence of multiple cell types within the peritoneum, different subtypes of resolving macrophages, and unclear time parameters, making it challenging to track and identify key molecules and epigenetic factors in vivo. 2. **Characteristics of Resolving Macrophages**: - **Low Inflammatory Factor Secretion**: Resolving macrophages (Mres-like/CD11blow) exhibit low levels of inflammatory cytokine and chemokine production, reducing the response to secondary inflammatory stimuli. - **Low Arginase Activity**: These cells have reduced arginase expression. - **High Phagocytic Index**: They have a high capacity for phagocytosing apoptotic cells (efferocytosis). - **Low CD11b Surface Integrin Expression**: The expression of CD11b surface integrin is reduced. 3. **Research Objectives**: - **Establish an In Vitro Model**: Using the Raw 264.7 macrophage cell line, establish an in vitro model that can simulate the polarization of resolving macrophages. - **Validate Model Effectiveness**: Validate the effectiveness and reliability of the model by detecting indicators such as gene expression, cytokine secretion, arginase activity, and phagocytic capacity at different time points. - **Screen Molecular Mechanisms**: Use this model to screen and identify key molecules and epigenetic factors that trigger the polarization of resolving macrophages, providing new avenues for further research and treatment of chronic inflammation. ### Research Methods: 1. **Inflammatory Pretreatment**: Use LPS and IFN-γ to pre-treat Raw 264.7 cells to generate classical inflammatory-like (M1-like) macrophages. 2. **Addition of Apoptotic Cells**: 2 hours after inflammatory pretreatment, add apoptotic Jurkat cells (apoJ) to induce the polarization of anti-inflammatory and resolving macrophages. 3. **Detection Indicators**: Use methods such as real-time PCR, ELISA, flow cytometry, and phagocytosis assays to detect indicators such as gene expression, cytokine secretion, arginase activity, and phagocytic capacity at different time points. ### Expected Results: - **Inflammatory Phase**: Within the initial 2-24 hours, Raw 264.7 cells exhibit a typical inflammatory-like (M1-like) phenotype, including increased IL-1β gene expression and increased TNF-α secretion. - **Anti-Inflammatory Phase**: At 22-24 hours, some cells begin to polarize into an anti-inflammatory-like (M2-like) phenotype, characterized by increased IL-10 gene expression. - **Resolution Phase**: By 48 hours, cells further polarize into a resolving-like (Mres-like/CD11blow) phenotype, characterized by a high phagocytic index, low inflammatory cytokine expression, low arginase activity, and low CD11b expression. Through this research, the authors hope to provide an effective in vitro model for studying the molecular mechanisms of resolving macrophages and to offer new tools for developing drugs that promote the resolution phase.

An modelling of resolving macrophage with Raw 264.7 macrophage cell line

Saturated-efferocytosis generates pro-resolving CD11b low macrophages: modulation by resolvins and glucocorticoids

Modelling the continuum of macrophage phenotypes and their role in inflammation

A systematic evaluation of the influence of macrophage phenotype descriptions on inflammatory dynamics

Identifying important parameters in the inflammatory process with a mathematical model of immune cell influx and macrophage polarization

Resolved vs. uncontrolled inflammation: a mathematical model to decipher the role of innate immunity

Macrophages polarize to the pro-inflammatory phenotype and delay neutrophil efferocytosis to augment Aggregatibacter actinomycetemcomitance JP2 clearance

Macrophage-Derived Protein S Facilitates Apoptotic Polymorphonuclear Cell Clearance by Resolution Phase Macrophages and Supports Their Reprogramming

Mitochondrial Fragmentation Promotes Inflammation Resolution Responses in Macrophages via Histone Lactylation

Single-cell transcriptomics identifies the differentiation trajectory from inflammatory monocytes to pro-resolving macrophages in a mouse skin allergy model

Transcriptomic Analysis of Monocyte-Derived Non-Phagocytic Macrophages Favors a Role in Limiting Tissue Repair and Fibrosis

Inflammatory M1-like macrophages polarized by NK-4 undergo enhanced phenotypic switching to an anti-inflammatory M2-like phenotype upon co-culture with apoptotic cells

New Lives Given by Cell Death: Macrophage Differentiation Following Their Encounter with Apoptotic Leukocytes during the Resolution of Inflammation

Damage-mediated macrophage polarization in sterile inflammation

Reprogramming M1-to-M2 Phenotype to Alleviate Inflammation: Using Liposomal Curcumin as a Tool to Redefine Macrophage Functionality

Large-scale computational modelling of the M1 and M2 synovial macrophages in rheumatoid arthritis

Proteolytic Shedding of Integrin Beta 2 Promotes Macrophage Resolution of Inflammation

Dynamic changes in macrophage polarization during the resolution phase of periodontal disease

Efferocytosis drives a tryptophan metabolism pathway in macrophages to promote tissue resolution

Detection of Lipopolysaccharide Induced Inflammatory Responses in RAW264.7 Macrophages Using Atomic Force Microscope

Proteomic Dissection of Agonist-Specific TLR-Mediated Inflammatory Responses on Macrophages at Subcellular Resolution